A carregar...

Biosimilar insulins: guidance for data interpretation by clinicians and users

Biosimilar insulins are approved copies of insulins outside patent protection. Advantages may include greater market competition and potential cost reduction, but clinicians and users lack a clear perspective on ‘biosimilarity’ for insulins. The manufacturing processes for biosimilar insulins are ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Heinemann, L., Home, P. D., Hompesch, M.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4744724/
https://ncbi.nlm.nih.gov/pubmed/25974131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12491
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!